Docking and Molecular Dynamic Simulations Study to Search Curcumin Analogue Compounds as Potential Inhibitor Against SARS-CoV-2: A Computational Approach
Open Access
- 29 March 2021
- journal article
- Published by Institute of Research and Community Services Diponegoro University (LPPM UNDIP) in Jurnal Kimia Sains dan Aplikasi
- Vol. 24 (3), 85-90
- https://doi.org/10.14710/jksa.24.3.85-90
Abstract
Coronavirus is a pandemic in the world. It requires researchers and scientists to work hard to find a vaccine or drug to inhibit the development of the coronavirus. Many drugs have been used, such as remdesivir, lopinavir, and chloroquine. However, how effective is the use of these drugs for inhibiting the coronavirus’s growth? There is no research has been done. Curcumin is now known as one of the compounds that have some biological activities, and it is also can potentially be used as a CoV-2 inhibitor. The computational study, i.e., molecular docking and molecular dynamic, can help researchers to predict which compounds have the potential as an inhibitor against the CoV-2 coronavirus. In this study, lopinavir was used as a positive control. Lopinavir and 45 curcumin analog compounds were docked against the main protease protein with 6LU7 PDB ID. Based on the docking results, it was discovered that compound 1, compound 2, and compound 4 have the same binding orientation as lopinavir. Molecular dynamic simulation with the lowest binding free energy conformation was used to check these compounds’ stability. Only compound 4 was maintained to observe hydrogen bonding with Lys5 and Lys137 with a distance of 2.9 Å. The distance of hydrogen bonds and binding free energy over simulation time is essential to elucidate the potential compound’s affinity. For then, compound 4 can be used as a potential inhibitor against the CoV-2 coronavirus.Keywords
Funding Information
- Sekolah Tinggi Ilmu Farmasi Riau
This publication has 10 references indexed in Scilit:
- Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studiesScientific Reports, 2021
- In silico studies and biological evaluation of chalcone-based 1,5-benzothiazepines as new potential H1N1 neuraminidase inhibitorsJournal of Applied Pharmaceutical Science, 2020
- Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitorsInternational Journal of Antimicrobial Agents, 2020
- Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory MechanismsBiochemistry, 2020
- New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?International Journal of Antimicrobial Agents, 2020
- Recent discovery and development of inhibitors targeting coronavirusesDrug Discovery Today, 2020
- Cross‐species transmission of the newly identified coronavirus 2019‐nCoVJournal of Medical Virology, 2020
- Synthesis, Structure-Activity Relationship, Docking and Molecular Dynamic Simulation of Curcumin Analogues Against HL-60 for Anti Cancer Agents (Leukemia)Oriental Journal of Chemistry, 2017
- Structural insights into Rab21 GTPase activation mechanism by molecular dynamics simulationsMolecular Simulation, 2017
- Cation-limited kinetic model for microbial extracellular electron transport via an outer membrane cytochrome C complexBiophysics and Physicobiology, 2016